Naperville, IL -- (SBWIRE) -- 02/06/2013 -- Daewoong Pharmaceutical Co., Ltd. - Product Pipeline Review - 2012 provides data on the Daewoong Pharmaceutical Co., Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from databases, Daewoong Pharmaceutical Co., Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Daewoong Pharmaceutical Co., Ltd. and industry-specific third party sources.
Scope
- Daewoong Pharmaceutical Co., Ltd. - Brief Daewoong Pharmaceutical Co., Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Daewoong Pharmaceutical Co., Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Daewoong Pharmaceutical Co., Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Daewoong Pharmaceutical Co., Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Daewoong Pharmaceutical Co., Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Daewoong Pharmaceutical Co., Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Daewoong Pharmaceutical Co., Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Daewoong Pharmaceutical Co., Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Daewoong Pharmaceutical Co., Ltd. and identify potential opportunities in those areas.
To view table of contents for this market report please visit:
http://www.reportstack.com/product/92891/daewoong-pharmaceutical-co-ltd-product-pipeline-review-2012.html